Piloting of NAVIFY Tumor Board startedPublished: August 28, 2018
The University of Missouri School of Medicine is one of the first Roche partners implementing the NAVIFY Tumor Board solutions for a first piloting phase. The NAVIFY Tumor Board solution is designed to streamline and standardize tumor board workflows digitally, reducing manual steps to a minimum, while optimizing the benefit for the cancer patient due to effective meetings. Being part of the story, inhive is proud to see Tumor Board taking the next steps. For more information follow https://medicine.missouri.edu/news/charting-course-future-tumor-boards .
IBM Watson – what’s behind?Published: July 15, 2018
Exciting symposium on cognitive computing and AI to advance precision medicine with data scientists from IBM giving insights into their recent techniques for predictive models and research projects such as drug discovery and metabolic networks. This event is organized by DayOne and baselarea.swiss taking place on July 20 at Hotel Stücki in Basel.
Why Compliance is important in R&DPublished: May 15, 2018
CEO Oliver Vettel will be giving a talk today on "Data Privacy Compliance" at the Life Sciences R&D Roundtable 2018. This event is hosted by SAP and Bio Deutschland to bring together several R&D stakeholders across the healthcare industry. If you are interested in this topic, simply get in touch with us.